American Well Corporation

American Well Corp. engages in the provision of online healthcare services. It offers a single platform to support all telehealth needs from urgent to acute and post-acute care, chronic care management, and healthy living. Its services include urgent care, behavioral health, breastfeeding support, chronic care, nutrition counseling, pediatrics, telestroke, and virtual primary care. The company was founded by Ido Schoenberg and Roy Schoenberg in June 2006 and is headquartered in Boston, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AMWL reports Q4 achievements, eyes revenue growth through Converge

AMWL's Q4 performance highlighted achievements in client migrations and strategic partnerships, with a focus on revenue growth for 2023.
Strengths include ACV growth, strong demand for behavioral health solutions, and the potential of the Converge platform to drive integration.
Challenges lie in revenue outlook impacted by customer churn, while opportunities exist in driving growth through Converge and service revenue.
Despite uncertainties, AMWL remains confident in its position in the digital care market and readiness to capitalize on market opportunities.

American Well (AMWL) reports Q1 growth amid margin challenges

AMWL's Q1 performance showed revenue growth but challenges in margins due to operational factors.
The company's focus on customer relationships and solution-based sales strategy are key strengths.
Opportunities lie in leveraging subscription revenue, market receptivity, and a strong financial position for future growth.
Challenges include margin pressures, limited growth avenues without mergers, and market scrutiny on key operational metrics.

American Well (AMWL) excels in Q2 with Converge migrations and international partnerships

AMWL's Q2 performance showcased strong client migrations, new wins, and international partnerships, with a focus on profitability.
Converge's modularity and end-to-end experience drive efficiency and positive renewals, while challenges include managing churn and pricing.
Opportunities in successful client migrations, market shift towards production platforms, and behavioral health integration are key growth areas.
Efforts to simplify the customer journey and accelerate ROI realization through modular approaches are underway for AMWL.

AMWL excels in Q3 with government wins and strategic partnerships

American Well Corporation's Q3 earnings call highlighted strong performance, strategic wins, and operational improvements positioning the company for future growth.
While facing challenges with legacy platforms, AMWL's focus on Converge, cost savings, and client engagement presents opportunities for enhanced profitability.
With a clear roadmap for growth and a focus on customer-centric solutions, AMWL is poised for significant revenue expansion and margin improvement in the coming years.

AMWL reports solid Q4 performance, eyes revenue growth opportunities

AMWL's Q4 performance reflects strategic advancements, high client satisfaction, and revenue diversification, positioning the company for future growth.
While facing challenges in achieving breakeven EBITDA and addressing subscription revenue declines, AMWL's strengths in market traction and sales model transformation offer growth opportunities.
Guidance for 2024 and 2025 outlines a clear path towards revenue growth, improved EBITDA, and leveraging Converge for enhanced customer value and revenue generation.

American Well (AMWL) reports strong Q1 growth and eyes retail expansion

American Well's Q1 performance showcased growth and cost structure improvements, with a focus on subscription revenue.
The company's strategic initiatives target efficiency improvements and higher-margin software subscriptions.
Opportunities lie in market shifts towards complete healthcare solutions and expansion with existing customers.
Challenges include cost initiatives towards profitability and addressing impacts of lower subscription software revenue.

American Well Corp. reports revenue growth and boosts EBITDA guidance

AMWL's Q2 2024 performance reflects positive revenue growth, improved gross profit margin, and adjusted EBITDA guidance raise, underlining the company's progress.
While facing challenges in achieving positive EBITDA and operational efficiency, AMWL's strengths in customer relationships, cost-cutting measures, and market positioning offer strategic advantages.
Opportunities for AMWL include optimizing spend, expanding client base, and leveraging its unique position in the digital healthcare market to drive future growth and profitability.

American Well Corp reports Q3 growth and strategic positioning

American Well Corporation (AMWL) demonstrated steady revenue growth and a commitment to strategic initiatives in Q3 2024.
While facing challenges in achieving profitability, the company's focus on cost alignment and growth positioning bodes well for future performance.
Opportunities in leveraging key contracts and subscription revenue growth position AMWL for continued success in the healthcare technology sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leader in digital care, has announced Chief Financial Officer (CFO) Mark Hirschhorn will take on an expanded role as chief operating officer, effective Jan. 1, 2025. Hirschhorn will now oversee the company's operational and growth strategies, including the clinical, sales and marketing teams, while continuing his responsibilities as CFO.

Amwell CFO Mark Hirschhorn Expands Leadership Role

American Well Corporation (NYSE:AMWL ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Mark Hirschhorn - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Ryan MacDonald - Needham & Company Stan Berenshteyn - Wells Fargo Jailendra Singh - Truist Securities Charles Rhyee - TD Cowen Dave Larsen - BTIG Operator Ladies and gentlemen, good afternoon. My name is Abby and I will be your conference operator today.

American Well Corporation (AMWL) Q3 2024 Earnings Call Transcript

While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

American Well (AMWL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

American Well Corporation (AMWL) came out with a quarterly loss of $2.87 per share versus the Zacks Consensus Estimate of a loss of $3.32. This compares to loss of $4 per share a year ago.

American Well Corporation (AMWL) Reports Q3 Loss, Misses Revenue Estimates

BOSTON, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, announced company leaders will participate in several upcoming investor conferences. Ido Schoenberg, M.D.

Amwell to participate in upcoming investor conferences

American Well (AMWL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

American Well Corporation (AMWL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, today announced Mark Hirschhorn will become Amwell Chief Financial Officer (CFO) effective Oct. 21, succeeding Robert “Bob” Shepardson, who has been in the role since 2021. Hirschhorn will oversee Amwell's financial operations, enterprisewide optimization and capital allocation activities, and will play a meaningful leadership role in guiding the company's strategy to support its long-term growth objectives and enhance shareholder value.

Amwell announces new chief financial officer

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, will report third quarter 2024 operating results on Wednesday, Oct. 30. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m.

Amwell to report third quarter 2024 operating results

Planet Fitness

Peloton

American Well, Peloton Interactive and Planet Fitness are included in this Analyst Blog.

The Zacks Analyst Blog American Well, Peloton Interactive and Planet Fitness

These three Health and Fitness stocks have strong growth potential for the rest of 2024. These are: AMWL, PTON, PLNT.

Buy 3 Health and Fitness Stocks to Enhance Your Portfolio Returns

AMWL adds Hello Heart to its clinical programs, offering heart health solutions to members with high blood pressure or cholesterol via its Converge platform.

Amwell Shares Rise After Expansion of Portfolio With Hello Heart

BOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in digital care, today announced Hello Heart, the digital leader in preventive heart health, is a partner in the Amwell clinical programs portfolio available on the Amwell Converge™ platform.

Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution

Boston, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in several investor conferences in September.

Amwell to Participate in Upcoming Investor Conferences

Global X Telemedicine & Digital Health ETF

Hims & Hers Health

Telemedicine stocks could do no wrong during the pandemic. With millions on lockdown and still in need of medical care, telemedicine stocks, like Teledoc Health (NYSE:TDOC) ranfrom about $80 to a high of $288.80.

3 Telemedicine Stocks Poised for Possible Healthcare Evolution

While the top- and bottom-line numbers for American Well (AMWL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

American Well (AMWL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

American Well Corporation (NYSE:AMWL ) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Sue Dooley - Head of Investor Relations Ido Schoenberg - Chairman and Chief Executive Officer Robert Shepardson - Chief Financial Officer Conference Call Participants Craig Hettenbaugh - Morgan Stanley Jack Wallace - Guggenheim Securities Matthew Shea - Needham & Company Jenny Cao - Truist Securities Jessica Tassan - Piper Sandler David - from BTIG Charles Rhyee - TD Cowen Operator Good afternoon. My name is Rob, and I will be your conference operator today.

American Well Corporation (AMWL) Q2 2024 Earnings Call Transcript

Telehealth provider Amwell on Wednesday (July 31) reported second-quarter revenue of $62.8 million (above guidance of $61.1 million), driven by $27.5 million in subscription revenue and $28.7 million from visits to Amwell Medical Group (AMG). Despite a net loss of $49.9 million — down from $73.

Amwell Beats Q2 Expectations on Subscription Revenue Strength

American Well Corporation (AMWL) came out with a quarterly loss of $3.36 per share versus the Zacks Consensus Estimate of a loss of $3.94. This compares to loss of $4.60 per share a year ago.

American Well Corporation (AMWL) Reports Q2 Loss, Tops Revenue Estimates

Boston, July 31, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL) a small-cap, growth healthcare company and a leading provider of healthcare software as a service, today announced financial results for the second quarter ended June 30, 2024. Visit Amwell's investor relations website at investors.amwell.com to view the second quarter 2024 earnings report.

Amwell Announces Results for Second Quarter 2024

American Well (AMWL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will American Well Corporation (AMWL) Report Negative Earnings Next Week? What You Should Know

Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31.

Amwell® to Report Second Quarter 2024 Operating Results

Boston, June 28, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a small-cap growth healthcare company and a leading provider of healthcare software as a service, today announced that its Board of Directors (the “Board”) has approved a 1-for-20 reverse stock split (“Reverse Split”) of its Class A common stock, Class B common stock and Class C common stock (collectively, the “Common Stock”), that is expected to become effective on July 10, 2024 at 5:00 p.m. EDT. The shares of the Company's Class A common stock are expected to begin trading on the New York Stock Exchange (“NYSE”) on a split-adjusted basis at the market open on July 11, 2024. No change will be made to the trading symbol for the Company's shares of Class A common stock, “AMWL”, in connection with the Reverse Split.

Amwell Announces Reverse Stock Split

Boston, June 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, today announces the appointment of Ricky Goldwasser to the company's Board of Directors, effective June 13.

Amwell Announces Appointment of Ricky Goldwasser to its Board of Directors

Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility Amwell CEO to join tech and health leaders from Apple, Stanford Health and others in discussing virtual care solutions that bolster accessibility

News for American Well Corporation Stock (AMWL)